ADNCD
ADNCD
ANTI-DIABETIC NATURAL COMPOUNDS DATABASE
Home
Mode of Action
Browse Information
About us
Contact us
Select Mode of Action
AMPK activators
CD38 Expression Downregulators
DPP-IV Inhibitors
Enzyme Inhibitors
GLP-1 agonists
GLUT4 activators
KATP channel Inhibitors
Natural compounds for other diabetes related issues
Natural compounds improving expression of Insulin Receptor
Natural compounds improving Glucose Uptake
Natural compounds improving Insulin Secretion
Natural compounds improving Insulin Sensitivity
Natural compounds modifying the level of Akt phosphorylation
Natural compounds reducing Diabetic Nephropathy/Diabetic Neuropathy/Diabetic Cataract/Cardio-vascular Complications
Natural compounds showing Hypoglycemic activity/Anti-diabetic activity
Natural compounds showing Insulin Mimetic Activity
Natural compounds showing Insulinotrophic effect
PPAR- γ, α and δ activation
SGLT2 inhibitors
Anti-diabetic mode of action:
Increasing Insulin Receptor expression
Natural compounds improving expression of Insulin Receptor
S.No.
Compound
Reference
Physicochemical Properties and Toxicity Risks
1
Bellidifolin
Tian et al., 2010
Properties and Risk Assessment
2
Methylswertianin
Tian et al., 2010
Properties and Risk Assessment
3
Nymphayol
Subash-babu et al., 2015
Properties and Risk Assessment
4
Gallotannin
Kanaujia et al., 2010
Properties and Risk Assessment
5
Berberine
Chen et al., 2010
Properties and Risk Assessment
6
Estrogen
Ahmed and Hassanein, 2012
Properties and Risk Assessment
7
Myricetin
Liu et al., 2007
Properties and Risk Assessment
8
Ginsenoside Rb1
Shang et al., 2008
Properties and Risk Assessment
9
6-Gingerol
Chakraborty et al., 2012
Properties and Risk Assessment